skip to content

Clinical Neurosciences

 
Read more at: PhD student Pranathi Prasad wins CSAR Student Award
Pranathi Prasad receiving her award

PhD student Pranathi Prasad wins CSAR Student Award

1 July 2025

Clinical Neurosciences PhD student Pranathi Prasad has won a CSAR student award for applied research. The the Cambridge Society for the Application of Research (CSAR) PhD Student Awards of £1,000 each, are intended to recognise outstanding research with real world application and to assist students to pursue their research...


Read more at: Double funding win for technology to tackle brain injury
Illustrative brain image for funding win for technology to tackle brain injury

Double funding win for technology to tackle brain injury

26 June 2025

Two cutting-edge medical technologies from Addenbrooke's to tackle brain injury are among 35 awarded a share of £3m from the National Institute for Health and Care Research (NIHR). The projects are funded through the Invention for Innovation (i4i) Funding At the Speed of Translation (FAST) 4 Awards supporting healthcare...


Read more at: Innovative FTD gene therapy trial recruiting in Cambridge

Innovative FTD gene therapy trial recruiting in Cambridge

18 June 2025

Addenbrooke’s Hospital is one of the sites participating in an innovative, international trial of a novel gene therapy that offers the potential of a cure for patients with a particular inherited form of frontotemporal dementia (FTD). FTD is the leading cause of dementia in those under the age of 65 years. It is a...


Read more at: Gita Khalili Moghaddam named one of top 13 women changemakers in the UK
Gita Khalili Moghaddam copyright University of Cambridge

Gita Khalili Moghaddam named one of top 13 women changemakers in the UK

17 June 2025

Gita Khalili Moghaddam has been named one of the top 13 women changemakers in the UK by the Royal Society. The award was given for the translational impact of her research and entrepreneurial activities. This work originated during her PhD at Cambridge under the supervision of Prof Chris Lowe and was been supported by...


Read more at: Brain injury survivors help shape new medical technologies

Brain injury survivors help shape new medical technologies

4 June 2025

Researchers based at Cambridge University Hospitals NHS Foundation Trust (CUH) have developed a programme to ensure that the development of medical technology is in line with the unmet needs of brain injury survivors. The programme was developed by James Piercy, an “expert by experience” of brain injury. James suffered a...


Read more at: Mina Ryten elected as Academy of Medical Sciences fellow

Mina Ryten elected as Academy of Medical Sciences fellow

22 May 2025

We are delighted to announce that Professor Mina Ryten, Centre Director for the UK DRI at Cambridge, has been elected as one of 54 exceptional biomedical and health scientists to the prestigious Academy of Medical Sciences Fellowship. Professor Ryten commented: “I’m deeply honoured to be elected to the Academy of Medical...


Read more at: Breakthrough for Global Movement to recognise Traumatic Brain Injury

Breakthrough for Global Movement to recognise Traumatic Brain Injury

20 May 2025

GENEVA, SWITZERLAND – In a significant advance for global health policy, the Ministry of Health of Pakistan has confirmed its official sponsorship of a ground-breaking resolution to recognize Traumatic Brain Injury (TBI) as a chronic, notifiable global health condition. "TBI is a global public health crisis hidden in plain...


Read more at: New paper explores gut dysfunction in Parkinson’s
Gut study header

New paper explores gut dysfunction in Parkinson’s

20 May 2025

Marta Camacho from the Williams-Gray lab has published a new paper defining the characteristics of gut dysfunction in Parkinson's disease. The role of gut dysfunction and its links to neurodegeneration is a very topical issue, with wide interest from both researchers and the media. In this Q&A Marta explains her...


Read more at: Metabolic driver of Parkinson’s offers new target for treatment

Metabolic driver of Parkinson’s offers new target for treatment

30 April 2025

Researchers led by Dr Sung Min Son and Prof David Rubinsztein (UK DRI at Cambridge) have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the condition. In Parkinson’s, a protein known as alpha-...


Read more at: Stefano Pluchino receives Experimental Medicine Trial Award from the International Progressive MS Alliance

Stefano Pluchino receives Experimental Medicine Trial Award from the International Progressive MS Alliance

29 April 2025

This international award has gone to three development projects in Canada and the United Kingdom, which will each receive €100,000 to begin planning for future clinical trials. Dr. Stefano Pluchino’s team is one of three projects to have received funding for clinical trial development projects as part of the International...